Biotinylated liposomes as potential carriers for the oral delivery of insulin
Nanomedicine: nanotechnology, biology and medicine, 2014•Elsevier
This study aimed to explore biotinylated liposomes (BLPs) as novel carriers to enhance the
oral delivery of insulin. Biotinylation was achieved by incorporating biotin-conjugated
phospholipids into the liposome membranes. A significant hypoglycemic effect and
enhanced absorption were observed after treating diabetic rats with the BLPs with a relative
bioavailability of 12.09% and 8.23%, based on the measurement of the pharmacologic effect
and the blood insulin level, respectively; this achieved bioavailability was approximately …
oral delivery of insulin. Biotinylation was achieved by incorporating biotin-conjugated
phospholipids into the liposome membranes. A significant hypoglycemic effect and
enhanced absorption were observed after treating diabetic rats with the BLPs with a relative
bioavailability of 12.09% and 8.23%, based on the measurement of the pharmacologic effect
and the blood insulin level, respectively; this achieved bioavailability was approximately …
Abstract
This study aimed to explore biotinylated liposomes (BLPs) as novel carriers to enhance the oral delivery of insulin. Biotinylation was achieved by incorporating biotin-conjugated phospholipids into the liposome membranes. A significant hypoglycemic effect and enhanced absorption were observed after treating diabetic rats with the BLPs with a relative bioavailability of 12.09% and 8.23%, based on the measurement of the pharmacologic effect and the blood insulin level, respectively; this achieved bioavailability was approximately double that of conventional liposomes. The significance of the biotinylation was confirmed by the facilitated absorption of the BLPs through receptor-mediated endocytosis, as well as by the improved physical stability of the liposomes. Increased cellular uptake and quick gastrointestinal transport further verified the ability of the BLPs to enhance absorption. These results provide a proof of concept that BLPs can be used as potential carriers for the oral delivery of insulin.
From the Clinical Editor
Diabetes remains a major source of mortality in the Western world, and advances in its management are expected to have substantial socioeconomic impact. In this paper, biotinylated liposomes were utilized as carriers of insulin for local delivery, demonstrating the feasibility of this approach in a rat model.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果